4,000
Participants
Start Date
August 31, 2024
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2024
Administration of the EUonQoL-Kit - Active Treatment questionnaire
Electronic questionnaire to be administered to patients in active treatment.
Administration of the EUonQoL-Kit - Survivors questionnaire
Electronic questionnaire to be administered to cancer survivors.
Administration of the EUonQoL-Kit - Palliative Care questionnaire
Electronic questionnaire to be administered to patients in palliative care.
Mother Teresa University Hospital, Tirana
Onkološki Inštitut Ljubljana, Ljubljana
Országos Onkológiai Intézet, Budapest
Cyprus Association of Cancer Patients and Friends (PASYKAF), Nicosia
Region Hovedstaden (Rigshospitalet), Hillerød
Kortrijk Kankercentrum AZ Groeninge, Kortrijk
Bulgarian Joint Cancer Network, Varna
Klinika za tumore Klinički bolnički centar Sestre milosrdnice, Zagreb
Comprehensive Cancer Center, Vienna
General Oncology Hospital of Athens - Saint Savvas, Athens
North Estonia Medical Centre, Tallinn
Istituto Europeo di Oncologia, IRCCS, Milan
Oncology Institute of Vojvodina, Kamenitz
Turkey Cancer Institute, Istanbul
Anadolu Medical Center, Gebze
Fundación Instituto Valenciano de Oncología (IVO), Valencia
lnstitut de Cancérologie de l'Ouest (ICO), Angers
Sihtasutus Tartu Ülikooli Kliinikum, Tartu
Masarykův onkologický ústav, Brno
Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt
Deutsches Krebsforschungszentrum (DKFZ), Heidelberg
Institut Curie, Paris
Comprehensive Cancer Center Munich, Munich
National Cancer Institute (Národný onkologický ústav), Bratislava
Gustave Roussy, Villejuif
"The Prof. Dr. Ion ChiricutaInstitute of Oncology (IOCN)", Cluj-Napoca
HUS Syöpäkeskus Helsingin Yliopistollinen Sairaala, Helsinki
Petre Shotadze Tbilisi Medical Academy, Tbilisi
Trinity St. James's Cancer Institute, Dublin
Istituto Tumori Giovanni Paolo II, IRCCS, Bari
Fondazione IRCCS Istituto Nazionale Tumori, Milan
Region Skåne - University Hospital Cancer Centre, Lund
Istituto Nazionale Tumori Regina Elena, Roma
Riga East University Hospital, Riga
National Cancer Institute, Vilnius
Oncologic Institute of Moldova, Chisinau
Netherlands Cancer Institute, Amsterdam
Oslo University Hospital (OUS), Oslo
Greater Poland Cancer Centre, Poznan
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warsaw
Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. (IPO-Porto), Porto
"Institutul Oncologic Al. Trestioreanu (IOB)", Bucharest
Vall Hebron Institute of Oncology (VHIO), Barcelona
Sahlgrenska comprehensive cancer centre, Gothenburg
Leeds Teaching Hospitals NHS Trust, Leeds
Collaborators (1)
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
German Cancer Research Center
OTHER
Oslo University Hospital
OTHER
The Netherlands Cancer Institute
OTHER
Hospital del Mar Research Institute
UNKNOWN
Istituto Europeo di Oncologia
OTHER
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
UNICANCER
OTHER
EAPC
UNKNOWN
Institut Curie
OTHER
EUROPEAN CANCER ORGANISATION
UNKNOWN
DIGICORE/IFO
UNKNOWN
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
NETWORK
Alleanza Contro il Cancro
OTHER
Istituti Fisioterapici Ospitalieri
OTHER
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG
UNKNOWN
University of Milan
OTHER
SporeData OÜ
UNKNOWN
ORGANISATION OF EUROPEAN CANCER INSTITUTES
UNKNOWN
FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA
UNKNOWN
Medical University Innsbruck
OTHER
SDRUZHENIE ASOTSIATSIA NA PATSIENTITE SONKOLOGICHNI ZABOLYAVANIA I PRIYATELI
UNKNOWN
FEDERATIA ASOCIATIILOR BOLNAVILOR DE CANCER
UNKNOWN
University of Leeds
OTHER
The Leeds Teaching Hospitals NHS Trust
OTHER
Region Hovedstaden (Bispebjerg Hospital & Rigshospitalet)
UNKNOWN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER